# Osanni Bio funding rounds and investors

As of 14 Oct 2026, Osanni Bio has raised $190M across 1 verified round on record; latest: $190 million Series B led by Patient Square Capital, announced 23 Jun 2026.

Osanni Bio, a development-stage therapeutics platform, is reinventing discovery and development of new medicines.

Website: https://osanni.bio  
Headquarters: San Francisco, California  
Page: https://fireround.dev/companies/osanni.bio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-06-23 | Series B | $190 million | Patient Square Capital | Horowitz Group, Invus Opportunities, Retinal Degeneration Fund | [businesswire.com](https://www.businesswire.com/news/home/20260623418949/en/Osanni-Bio-Closes-%24190-Million-Series-B-Financing-Led-by-Patient-Square-Capital) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.